0000950170-23-045084.txt : 20230829 0000950170-23-045084.hdr.sgml : 20230829 20230829163226 ACCESSION NUMBER: 0000950170-23-045084 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230828 FILED AS OF DATE: 20230829 DATE AS OF CHANGE: 20230829 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Werner Michelle C CENTRAL INDEX KEY: 0001991154 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40657 FILM NUMBER: 231222353 MAIL ADDRESS: STREET 1: C/O OMEGA THERAPEUTICS, INC. STREET 2: 20 ACORN PARK D CITY: CAMBRIDGE STATE: MA ZIP: 02140 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Omega Therapeutics, Inc. CENTRAL INDEX KEY: 0001850838 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 140 FIRST STREET, SUITE 501 CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: (617) 949-4360 MAIL ADDRESS: STREET 1: 140 FIRST STREET, SUITE 501 CITY: CAMBRIDGE STATE: MA ZIP: 02141 4 1 ownership.xml 4 X0508 4 2023-08-28 0001850838 Omega Therapeutics, Inc. OMGA 0001991154 Werner Michelle C C/O OMEGA THERAPEUTICS, INC. 140 FIRST STREET, SUITE 501 CAMBRIDGE MA 02141 true false false false false Stock Option (Right to Buy) 3.62 2023-08-28 4 A false 36713 0.00 A 2033-08-27 Common Stock 36713 36713 D The option vests and becomes exercisable in thirty-six substantially equal monthly installments following the date of grant, such that the option shall be fully vested and exercisable on the third anniversary of the date of grant, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such vesting date. /s/ Barbara Chan as Attorney-in-Fact for Michelle C. Werner 2023-08-29